SCHEMBL7693197

SCHEMBL7693197

O=C(O)NCCc1ccc(Nc2ncccc2[N+](=O)[O-])cc1.O=[N+]([O-])c1cccnc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
MAPT P10636 4/20 0.53
NFKB1 P19838 1/20 0.53
MAPK1 P28482 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
ITGB1 P05556 1/20 0.44
ITGA4 P13612 1/20 0.44
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CNR1 P21554 1/20 0.40
FFAR1 O14842 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
DHODH Q02127 1/20 0.40
PTPN1 P18031 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693196 1.00 NPC1 (0.53) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL7161060 0.94 MAPT (0.59) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL7161066 0.94 MAPT (0.59) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL30802494 0.84 MAPT (0.63) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL27963761 0.81 MAPT (0.60) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL7691144 0.79 NPC1 (0.49) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL7158528 0.77 MAPT (0.64) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL20603943 0.76 MAPT (0.65) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL30826715 0.76 MAPT (0.64) NPC1RAB9AMAPTNFKB1MAPK1
SCHEMBL12970394 0.76 MAPT (0.64) NPC1RAB9AMAPTNFKB1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002006235-A1 HETEROCYCLIC BETA-3 ADRENERGIC RECEPTOR AGONISTS WYETH (US) 2002-01-24 WO disclosed